FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Order BPC 157 (20mg) Buy Research Peptides Medica Depot Are Peptides coming off of the FDA Category 2 list? A legal breakdown.